Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-10 Sale | 2024-01-12 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 8,000 | $27.91 | $223,280 | 85,664 (Direct) | View |
| 2023-08-30 Sale | 2023-09-01 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 8,100 | $32 | $259,200 | 99,149 (Direct) | View |
| 2023-08-25 Sale | 2023-08-29 5:00 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 5,135 | $31.59 | $162,215 | 85,249 (Direct) | View |
| 2022-08-22 Sale | 2022-08-23 5:16 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 5,000 | $35.98 | $179,900 | 87,220 (Direct) | View |
| 2022-08-04 Sale | 2022-08-05 4:31 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 5,000 | $32.98 | $164,900 | 92,220 (Direct) | View |
| 2021-04-13 Sale | 2021-04-14 8:24 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 6,250 | $30.98 | $193,639 | 101,951 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-23 Option Award | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 1,250 | $0 | 90,683 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 485 | $29.06 | 90,683 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 1,250 | $0 | 90,683 (Direct) | View |
| 2024-02-22 Tax Withholding | 2024-02-26 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 246 | $27.94 | 87,668 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 750 | $0 | 87,668 (Direct) | View |
| 2024-02-22 Disposition | 2024-02-26 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 750 | $0 | 87,668 (Direct) | View |
| 2024-01-10 Exercise | 2024-01-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 8,000 | $9.24 | 85,664 (Direct) | View |
| 2024-01-10 Exercise | 2024-01-12 5:00 pm | N/A 2024-01-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 8,000 | $0 | 85,664 (Direct) | View |
| 2023-08-30 Exercise | 2023-09-01 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 8,100 | $23.99 | 99,149 (Direct) | View |
| 2023-08-30 Exercise | 2023-09-01 5:00 pm | N/A 2030-02-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 8,100 | $0 | 99,149 (Direct) | View |
| 2023-02-22 Option Award(A) | 2023-04-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 750 | $0 | 92,284 (Direct) | View |
| 2023-02-22 Disposition(A) | 2023-04-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 750 | $0 | 92,284 (Direct) | View |
| 2023-02-22 Tax Withholding(A) | 2023-04-12 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 289 | $38.57 | 92,284 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:03 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 25,000 | $0 | 115,323 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 750 | $0 | 92,573 (Direct) | View |
| 2023-02-22 Disposition | 2023-02-24 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 750 | $0 | 92,573 (Direct) | View |
| 2023-02-16 Exercise | 2023-02-21 5:01 pm | N/A 2031-04-30 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 1,500 | $0 | 88,720 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 5:02 pm | N/A 2031-04-30 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 1,500 | $0 | 88,720 (Direct) | View |
| 2022-08-22 Exercise | 2022-08-23 5:16 pm | N/A 2023-02-05 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 5,000 | $0 | 87,220 (Direct) | View |
| 2022-08-22 Exercise | 2022-08-23 5:16 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 5,000 | $7.9 | 87,220 (Direct) | View |
| 2022-08-04 Exercise | 2022-08-05 4:31 pm | N/A 2023-02-05 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 5,000 | $0 | 92,220 (Direct) | View |
| 2022-08-04 Exercise | 2022-08-05 4:31 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 5,000 | $7.9 | 92,220 (Direct) | View |
| 2022-02-22 Option Award(A) | 2022-02-25 5:17 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 21,000 | $0 | 108,220 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:22 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 21,000 | $0 | 108,220 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-14 8:24 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 6,250 | $12.98 | 101,951 (Direct) | View |
| 2021-04-13 Exercise | 2021-04-14 8:24 pm | N/A 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 6,250 | $0 | 101,951 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:54 pm | N/A 2031-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 17,000 | $0 | 103,326 (Direct) | View |
| 2020-02-21 Option Award | 2020-02-25 6:33 pm | N/A 2030-02-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 22,000 | $0 | 107,279 (Direct) | View |
Ownership | 2020-02-25 6:31 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Martin Tami Tillotson Sr. V.P., Regulatory Affairs | 0 | $0 | 186,279 (Direct) | View |